The company received a price target increase from Cantor Fitzgerald to $70 from $60 with an Overweight rating following its Q3 2025 earnings. It is recognized for its surging revenues, stronger balance sheet, key quantum milestones, and major partnerships, fueling excitement despite remaining unprofitable. However, the stock is down 40% from its recent all-time high, and some analysts caution that the quantum computing industry is still nascent and years away from being commercially significant, suggesting investors look beyond speculative start-ups.